Gabinet Pulmonologii i Diagnostyki Chorób Alergicznych Dorota Maria Małosek
- Address
- ul. Powstańców Wielkopolskich 66-68, 70-111 Szczecin, Poland
Gabinet Pulmonologii i Diagnostyki Chorób Alergicznych Dorota Maria Małosek
A specialized pulmonology and allergy diagnostic center dedicated to advancing respiratory medicine through clinical research and patient care. The facility focuses on complex respiratory conditions and participates in innovative therapeutic trials to improve treatment outcomes for patients with challenging pulmonary disorders.
- Refractory and unexplained chronic cough management
- Novel inhalation therapies and respiratory drug development
- Allergic respiratory disease diagnosis and treatment
The center contributes to breakthrough research in chronic cough treatment, including evaluation of emerging therapies such as Taplucainium Inhalation Powder for patients with refractory or unexplained chronic cough. Through participation in controlled clinical trials, the facility helps establish evidence-based protocols for managing difficult-to-treat respiratory conditions, particularly those resistant to conventional therapeutic approaches.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gabinet Pulmonologii i Diagnostyki Chorób Alergicznych Dorota Maria Małosek
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Taplucainium Chloride Inhalation Powder in Adults with Refractory or Unexplained Chronic Cough: A Randomized, Double-Blind, Placebo-Controlled Study | Nocion Therapeutics Inc. | Phase II | Not Recruiting | Dec 2024 | Jun 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Taplucainium Chloride | 1 | Unknown | 2024-12-18 | 2024-12-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.